DataLend: Securities Lending Revenue Down 16% Year-Over-Year to $2.53 Billion in Q2 2024
Global revenue declines year-over-year due to lagging equities performance in the U.S. and EMEA NEW YORK, July 2, 2024 /PRNewswire/ -- The global securities finance industry generated $2.53 billion i
China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio?
These mid-cap stocks were the best performers in the last week. Are they in your portfolio?Bilibili Inc. (NASDAQ:BILI) shares rose 23.32% following last week's release of 'San Guo: Mou Ding Tian Xia.'
ImmunityBio Shares Are Trading Higher on Continued Strength After the Company on Thursday Announced Insurance Coverage of ANKTIVA Across Multiple States With First Commercial Doses Administered.
ImmunityBio Shares Are Trading Higher on Continued Strength After the Company on Thursday Announced Insurance Coverage of ANKTIVA Across Multiple States With First Commercial Doses Administered.
Sector Update: Health Care Stocks Mixed Thursday Afternoon
Health care stocks were mixed Thursday afternoon, with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%. The iShares Biotechnology ETF (IBB) rose 0.9%. In
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results.Jabil reported third-quarter fiscal 2024 revenue of $6.77 billion, down by 20.2% year-on-year, be
Why ImmunityBio Stock Is Trading Higher Thursday
ImmunityBio, Inc. (NASDAQ:IBRX) shares are moving higher Thursday after the company announced insurance coverage of ANKTIVA across multiple states.The Details: ANKTIVA is a immunotherapy used to treat
ImmunityBio Spikes After Commercial Update on Lead Drug Anktiva
KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index gaining around 150 points on Thursday.Shares of KB Home (NYSE:KBH) rose during Thursday's session as the company posted better-than-expected earnings a
ImmunityBio's Bladder Cancer Treatment Anktiva Launches in US
ImmunityBio (IBRX) said Thursday that it has launched Anktiva, its immunotherapy to treat Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer, with multiple patients across the US
Express News | Immunitybio Announces Insurance Coverage of Anktiva® Across Multiple States With First Commercial Doses Administered Just Weeks After FDA Approval—Opening New Era for Immunotherapy Beyond Checkpoint Inhibitors
Chief Scientific Officer Patrick Soon-Shiong, ImmunityBio, Inc.'s (NASDAQ:IBRX) Largest Shareholder Sees Value of Holdings Go Down 4.5% After Recent Drop
Key Insights ImmunityBio's significant insider ownership suggests inherent interests in company's expansion The top 2 shareholders own 62% of the company Institutional ownership in ImmunityBio is
Daily Options Tracking | Tesla rose more than 6% in pre-market trading, with big players selling put options betting on the rise; Apple's one call option earned a profit of three times the investment, and options trading increased by 400%!
Gamestop's overnight option trading volume was 1.21 million lots, an increase of nearly 60% compared to the daily average trading volume. The call ratio dropped to 63%. It is worth noting that the call with a maturity date of June 21 and a strike price of $20 held by 'Roaring Little Cat' ranked first in trading volume with 93,000 lots traded and about 170,000 lots of open positions.
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Express News | Immunitybio Announces 2024 Annual Meeting of Stockholders With Company Update
ImmunityBio, LadRx End Licensing Deal for Cancer Drug
Daily options tracking | Gamestop surged 21% overnight, one call option yielded a profit of 9 times; Nvidia call options ratio increased to 60%, multiple call options were traded vigorously.
Dell fell more than 5% overnight, with options volume of 250,000 contracts, nearly doubled from the daily average volume. The call/put ratio rose to 65%, causing volatile sentiment in the options chain. Active transactions include the call with a strike price of $140 and the put with a strike price of $1,300, both expiring this Friday, with trading volumes of 13,000 contracts and 11,000 contracts respectively, both with open interest of nearly 3,000 contracts. In addition, the premium for multiple puts expiring on the same day doubled.
Express News | Ladrx and Immunitybio mutually agree to terminate the Aldoxorubicin license.
Express News | Ladrx and Immunitybio Mutually Agree to Terminate Aldoxorubicin License
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
How Is The Market Feeling About ImmunityBio?
ImmunityBio's (NYSE:IBRX) short percent of float has fallen 8.79% since its last report. The company recently reported that it has 55.14 million shares sold short, which is 35.26% of all regular share